Trial Profile

MAcrophage Therapy for Liver Cirrhosis (MATCH)

Status: Recruiting

Phase of Trial: Phase I/II

Latest Information Update: 04 Apr 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs RTX 001 Resolution Therapeutics (Primary)
Indications Liver cirrhosis
Focus Adverse reactions; First in man
Acronyms MATCH; MATCH01

Most Recent Events

01 Mar 2025 Primary endpoint has not been met (Phase I dose escalation study).
01 Mar 2025 Results (n=51) published in the Nature Medicine.
11 Nov 2024 According to Resolution Therapeutics Limited media release, data from the study will be presented in oral and poster presentations at the American Association for the Study of Liver Disease (AASLD) The Liver Meeting 2024, which is being held in San Diego, California from 15-19 November 2024.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com